Published in BMC Infect Dis on April 15, 2011
Early results of systematic drug susceptibility testing in pulmonary tuberculosis retreatment cases in Cameroon. BMC Res Notes (2012) 1.22
Relatively low primary drug resistant tuberculosis in southwestern Ethiopia. BMC Res Notes (2012) 1.10
Non-conversion of sputum culture among patients with smear positive pulmonary tuberculosis in Cameroon: a prospective cohort study. BMC Infect Dis (2014) 0.96
High rates of ofloxacin resistance in Mycobacterium tuberculosis among both new and previously treated patients in Tamil Nadu, South India. PLoS One (2015) 0.82
Mycobacterium tuberculosis is the causative agent of tuberculosis in the southern ecological zones of Cameroon, as shown by genetic analysis. BMC Infect Dis (2013) 0.81
Evaluation of customised lineage-specific sets of MIRU-VNTR loci for genotyping Mycobacterium tuberculosis complex isolates in Ghana. PLoS One (2014) 0.81
HIV and tuberculosis trends in the United States and select Sub-Saharan Africa countries. Int J Environ Res Public Health (2011) 0.79
Drug resistance profiles of Mycobacterium tuberculosis complex and factors associated with drug resistance in the Northwest and Southwest Regions of Cameroon. PLoS One (2013) 0.78
Strong decrease in streptomycin-resistance and absence of XDR 12 years after the Reorganization of the National Tuberculosis Control Program in the Central Region of Cameroon. PLoS One (2014) 0.76
Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet (2006) 21.60
[Measurement of sensitivity of the tuberculous bacillus to antibacillary drugs by the method of proportions. Methodology, resistance criteria, results and interpretation]. Rev Tuberc Pneumol (Paris) (1963) 5.58
Global incidence of multidrug-resistant tuberculosis. J Infect Dis (2006) 5.42
HIV infection and multidrug-resistant tuberculosis: the perfect storm. J Infect Dis (2007) 5.40
Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. International Union Against Tuberculosis and Lung Disease. Clin Infect Dis (1997) 4.02
Genetic biodiversity of Mycobacterium tuberculosis complex strains from patients with pulmonary tuberculosis in Cameroon. J Clin Microbiol (2003) 2.69
Molecular diagnosis of mycobacteria. Clin Chem (2001) 2.57
Tuberculosis morbidity in the United States: final data, 1990. MMWR CDC Surveill Summ (1991) 2.53
Tuberculosis control and molecular epidemiology in a South African gold-mining community. Lancet (2000) 2.26
Multidrug-resistant tuberculosis and its control. Res Microbiol (1993) 2.02
Anti-tuberculosis drug resistance in the West Province of Cameroon. Int J Tuberc Lung Dis (2000) 1.31
Anti-tuberculosis drug resistance surveillance in Uganda 1996-1997. Int J Tuberc Lung Dis (1999) 1.27
Acquired anti-tuberculosis drug resistance in Yaounde, Cameroon. Int J Tuberc Lung Dis (2000) 0.99
Initial resistance to antituberculosis drugs in Yaounde, Cameroon in 1995. Int J Tuberc Lung Dis (1997) 0.97
[Resistance of mycobacterial tuberculosis complex to the main antibacillary agent in Yaounde, Cameroon]. Bull Soc Pathol Exot (1998) 0.94
CamMedNP: building the Cameroonian 3D structural natural products database for virtual screening. BMC Complement Altern Med (2013) 1.05
Integrated dataset of screening hits against multiple neglected disease pathogens. PLoS Negl Trop Dis (2011) 1.03
Low anticoagulant heparin disrupts Plasmodium falciparum rosettes in fresh clinical isolates. Am J Trop Med Hyg (2011) 1.02
Antimicrobial and toxicological activities of five medicinal plant species from Cameroon traditional medicine. BMC Complement Altern Med (2011) 0.90
Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon. Infect Dis Poverty (2014) 0.82
Mycobacterium tuberculosis is the causative agent of tuberculosis in the southern ecological zones of Cameroon, as shown by genetic analysis. BMC Infect Dis (2013) 0.81
Sequence analysis for detection of drug resistance in Mycobacterium tuberculosis complex isolates from the Central Region of Cameroon. BMC Microbiol (2014) 0.80
Design, synthesis, and biological activities of closantel analogues: structural promiscuity and its impact on Onchocerca volvulus. J Med Chem (2011) 0.78
Molecular genotyping of Mycobacterium bovis isolated from cattle tissues in the North West Region of Cameroon. Trop Anim Health Prod (2012) 0.78
Drug resistance profiles of Mycobacterium tuberculosis complex and factors associated with drug resistance in the Northwest and Southwest Regions of Cameroon. PLoS One (2013) 0.78
Identification of in vivo released products of Onchocerca with diagnostic potential, and characterization of a dominant member, the OV1CF intermediate filament. Infect Genet Evol (2010) 0.77